Development of this evidence summary

This evidence summary was developed for NICE by Bazian Ltd. The interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.

Project team

Bazian Ltd

Louisa Crossley, Medicines and Prescribing Centre, NICE

Peer reviewers and contributors

Teresina Pinnington, ARJUN Products Ltd

Victoria Thomas, Patient and Public Involvement Programme, NICE

Expert advisers

Dr John Ayuk, Department of Endocrinology, Queen Elizabeth Hospital, Birmingham

Declarations of interest

No relevant interests declared.